Clinical Trial Update: Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia [Phase 3]

View source ↗

Summary

This document reports a completed Phase 3 trial evaluating rivastigmine capsules for probable vascular dementia. It focuses on efficacy and safety outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vascular Dementia

Drugs mentioned

• Rivastigmine capsules (rivastigmine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Vascular Dementia | Phase 3 | Status: COMPLETED